JW

JOEL WHITE

HORIZON GOVERNMENT AFFAIRS · Washington, DC
Not currently registered

At a glance

Status
Inactive
last filed Apr 2025
Clients
0
past 12 months
Filings
0
0 agencies · past 12 months
Activity
filings by quarter

Background

Career
Washington, DC
2024 - present
Government experience
Former Staff Director
Ways & Means Health Subcommittee; L.A. for Rep. Jim Greenwood; L.A. for Rep Chris Shay
Disclosed on LD-2 filings
Former Staff Director
House Ways & Means Health Subcommittee; L.A. for Rep. Chris Shays
Disclosed on LD-2 filings
Former Staff Director
Ways & Means Health Subcommittee; L.A. for Rep. Jim Greenwood; L.A. for Rep Chris Shays
Disclosed on LD-2 filings
Former Staff Director
Ways and Means Health Subcommittee; L.A. for Rep. Jim Greenwood; L.A. for Rep. Chris Shays
Disclosed on LD-2 filings
Former Staff Director
House Ways & Means Health Subcommittee; L.A. for Rep. Jim Greenwood; L.A. for Rep. Chris Shays
Disclosed on LD-2 filings

Specific issues

Issues around electronic healthcare standards and interoperability, funding for standards development and integration, technology-based patient safety solutions.
Health Issues · 2025 Q1
Issues around interoperability, data privacy and sharing in healthcare, drug shortages and healthcare transparency and PBM reform legislation.
Health Issues · 2025 Q1
Issues related to insurance agent and broker fees in Medicare, Proposed Rule-Medicare Program; Contract Year 2025 Policy and Technical Changes (CMS-4205-P) and Final Rule - Medicare Program; Contract Year 2025 Policy and Technical Changes (CMS-4205-F)
Medicare/Medicaid · 2025 Q1
Issues relating to Immunization Information System modernization, public health data modernization, and public health program reauthorization.
Health Issues · 2025 Q1
Health Reform; Value-Based Purchasing; Drug Pricing; Employer coverage
Health Issues · 2025 Q1
Medicare Part B Issues; Drug pricing and access, including Inflation Reduction Act; Drug shortage issues; Medicare physician reimbursement issues; HR 405-EMSSA; HR 5378-Lower Costs, More Transparency Act; S.2973-Modernizing and Ensuring PBM Accountability Act; HR 5526-Seniors'Access to Critical Medications Act of 2023; S.2764 and HR 5391, the Protecting Patient Access to Cancer and Complex Therapies Act, Seniors Access to Critical Medications Act (H.R. 5526).
Health Issues · 2025 Q1

Clients

No client work disclosed in the past 12 months.

Past clients12
$██,███ / qtrUnlock
2024-2025 · 5 filings
$██,███ / qtrUnlock
2024-2025 · 5 filings
$██,███ / qtrUnlock
2024-2025 · 5 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
$██,███ / qtrUnlock
2024-2025 · 5 filings
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock

Filings · past 12 months

Nothing filed in the past 12 months.

Older filings20
2025 Q1
MCKESSON CORPORATION
Q1lda.gov →
2025 Q1
NATIONAL COUNCIL FOR PRESCRIPTION DRUG PROGRAMS
Q1lda.gov →
2025 Q1
INTEGRITY MARKETING GROUP
Q1lda.gov →
2025 Q1
STCHEALTH LLC
Q1lda.gov →
2025 Q1
COUNCIL FOR AFFORDABLE HEALTH COVERAGE
Q1lda.gov →
2025 Q1
PHRMA
Q1lda.gov →
2025 Q1
CENCORA FKA AMERISOURCEBERGEN CORPORATION
Q1lda.gov →
2024 Q4
INTEGRITY MARKETING GROUP
Q4lda.gov →
2024 Q4
MCKESSON CORPORATION
Q4lda.gov →
2024 Q4
STCHEALTH LLC
Q4lda.gov →
2024 Q4
NATIONAL COUNCIL FOR PRESCRIPTION DRUG PROGRAMS
Q4lda.gov →
2024 Q4
COUNCIL FOR AFFORDABLE HEALTH COVERAGE
Q4lda.gov →
2024 Q4
CENCORA FKA AMERISOURCEBERGEN CORPORATION
Q4lda.gov →
2024 Q4
PHRMA
Q4lda.gov →
2024 Q4
STRIVE HEALTH
Q4lda.gov →
2024 Q4
US RENAL CARE
Q4lda.gov →
2024 Q4
DAVITA, INC.
Q4lda.gov →
2024 Q4
INTERWELL HEALTH
Q4lda.gov →
2024 Q3
STCHEALTH LLC
Q3lda.gov →
2024 Q3
NATIONAL COUNCIL FOR PRESCRIPTION DRUG PROGRAMS
Q3lda.gov →
Full record on lda.gov